WorkSafe has granted an exemption (SEP2405) to New Zealand Pharmaceuticals Limited from compliance with:
- for the Biochem Plant: regulations 11.36(2)(c) (in so far as it applies to the prescribed fire resistance ratings of walls, ceiling and doors, and compliance of windows with NZS 4232.2:1988; and compliance with secondary containment), 11.37(2)(b)(i), 11.37(2)(c), 11.37(3), and 11.37(4); and
- for the Pure Area: regulation 11.36(2)(c) (in so far as it applies to the fire resistance rating of the personnel door identified as door set D01/644518 [2024])
of the Health and Safety at Work (Hazardous Substances) Regulations 2017 (the HS Regulations) in relation to their manufacturing site at 68 Weld Street, Palmerston North.
The exemption is granted by WorkSafe in accordance with section 220 of the Health and Safety at Work Act 2015 (the Act) on the basis that WorkSafe is satisfied that—
- The extent of the exemption is not broader than is reasonably necessary to address the matters that gave rise to it; and
- The exemption is not inconsistent with the purpose of the Act as:
- the risks associated with the Biochem Plant can be mitigated by the alternative safety measures in place, including type 4 fire and smoke alarm systems, and vapor detection systems; and
- the existing -/120/60 minute fire rated door in the Pure Area will not increase the risk to worker health and safety when considered alongside the fire safety systems already in place in that area; and
- This is a situation where there is good reason to grant an exemption under section 220(1).
The exemption comes into effect on 06 July 2026 and expires on 06 July 2031 unless it is replaced sooner or revoked.
Last updated